SRES 602 is a symbolic Senate resolution expressing support for the U.S. Olympic and Paralympic Teams (Team USA) competing in the 2026 Winter Games in Milano Cortina, Italy. It formally applauds Team USA athletes, coaches, and their supporters, commends Italy for hosting the event, and commits to ensuring safety for future U.S. host events (2028 Los Angeles Summer Games and 2034 Utah Winter Games). The resolution does not create new policies, funding, or obligations - it is purely a statement of congressional support. It directly affects Team USA athletes and organizers by acknowledging their efforts and achievements. This is a procedural resolution with no binding effect on government actions.
HRES 1082 is a symbolic resolution recognizing 250 years of Polish-American friendship and affirming U.S. support for Poland’s democracy, sovereignty, prosperity, and security. It specifically calls for continued U.S. military stationing in Poland to support defense coordination and training with Polish forces, and expresses gratitude for Poland’s historical and ongoing partnership, including recent support for Ukraine. The resolution highlights key milestones like Poland’s NATO membership, defense investments, and refugee assistance for Ukrainians. As a non-binding resolution, it does not change laws but formally strengthens diplomatic recognition of the alliance.
HRES 1084 designates February 28 as "HIV is Not a Crime Awareness Day" to address the criminalization of people living with HIV. The resolution calls for ending state laws that impose harsh penalties or criminalize consensual acts based solely on HIV status - regardless of transmission risk, intent, or disclosure - and notes these laws disproportionately impact Black and brown communities, Black women, and transgender women. It urges education for law enforcement and communities, removal of outdated HIV criminalization laws, and increased support for HIV prevention, testing, treatment, and care programs. The resolution does not create new laws but advocates for policy changes to align with current medical understanding and reduce stigma.
HRES 1079 is a non-binding House resolution recognizing Charcot-Marie-Tooth disease (CMT) as a significant health condition affecting approximately 126,000 people in the U.S. and millions globally. It expresses the House’s support for increased federal funding for CMT research at the National Institute of Neurological Disorders and Stroke (NINDS) within the National Institutes of Health (NIH). The resolution specifically highlights that CMT research funding decreased in 2022 compared to 2021 and emphasizes the need for sustained investment in studying this inherited nerve disorder, which currently has no cure. As a recognition resolution, it does not allocate funds but formally urges continued NIH support for CMT and rare disease research.
HRES 1080 is a symbolic resolution recognizing and celebrating Black History Month 2026, focusing on its theme "A Century of Black History Commemorations." It highlights historical figures and events central to Black history, including Carter G. Woodson’s founding of Negro History Week (the precursor to Black History Month), Juneteenth, and key moments like the 1865 Charleston commemoration. The resolution emphasizes how Black history commemorations counter historical erasure and affirm Black contributions to U.S. history, referencing figures like Mary McLeod Bethune and W.E.B. Du Bois. As a ceremonial resolution, it has no binding effect but aims to raise awareness of Black achievements through official recognition.
S 3914 establishes two new offices within the Supreme Court: an Office of Ethics Counsel to advise justices and their spouses on ethics matters (like financial disclosures, gifts, and conflicts of interest), and an Office of Investigative Counsel to review formal ethics complaints filed by top congressional leaders. The Ethics Counsel provides mandatory biannual training to justices and submits annual reports to Congress on ethics advice given. The Investigative Counsel handles complaints, conducts investigations within 60 days of filing, and submits findings to the Chief Justice (or senior associate justice if the Chief is the subject), with reports also shared with relevant congressional committees. This bill directly affects Supreme Court justices, their spouses, and dependents by creating formal processes for ethics guidance and oversight.
The Government Surveillance Transparency Act of 2026 requires federal, state, and tribal courts to publicly disclose criminal surveillance orders, applications, and inventories after a maximum 180-day sealing period, with strict requirements for extensions. The bill mandates courts to publish detailed public reports about surveillance requests, including the nature of investigations and the agencies involved, and requires electronic filing of all surveillance documents. It creates a unique case numbering system for surveillance orders and requires automatic unsealing of documents after the sealing period expires. The law applies to all courts conducting surveillance, with implementation phased to allow time for system upgrades, and aims to increase transparency around government surveillance activities while balancing legitimate law enforcement needs.
This bill, known as Gwenn's Law, directs the National Institutes of Health to launch public awareness campaigns aimed at increasing women's participation in clinical trials, with a specific focus on research for rare diseases. It authorizes $10 million annually from 2027 to 2031 to fund these outreach efforts at hospitals, clinics, and other healthcare locations. The legislation also establishes a permanent interagency task force within HHS to coordinate rare disease research and requires the department to submit a public action plan within 180 days outlining how to improve treatment options for rare conditions that disproportionately affect women.
HR 7693, "Leo’s Law," extends existing exclusivity protections for certain orphan drugs by 180 days to address pandemic-related delays. It applies to drugs designated for rare diseases that had applications submitted during the COVID-19 emergency period (Dec 2019-March 2023), were approved under specific pathways, and have no non-rare disease indications. Key provisions extend periods like the 12-year market exclusivity under the Public Health Service Act and 5-year protections under the Federal Food, Drug, and Cosmetic Act. The bill does not create new incentives but temporarily lengthens existing protections for drug developers already navigating pandemic disruptions. This change applies only to qualifying orphan drugs meeting all specified criteria during the defined emergency period.
HR 7678, the Gun Owner Registration Information Protection Act, prohibits federal funding for state or local databases that track lawfully owned firearms or their owners. The bill allows federal funding for databases recording lost or stolen firearms but bans it for databases listing legal gun ownership. This means states cannot use federal money to create or maintain systems that compile information about legally owned guns. The bill directly affects state and local governments that rely on federal funds for firearm ownership databases.
This bill prohibits using federal funds - including the Judgment Fund or victim compensation programs - to pay any individual prosecuted for the January 6 Capitol attack, even if later pardoned. It also bans creating new compensation funds for these individuals and stops refunds of court-ordered payments like restitution or fines from being returned to rioters. Any funds that would have been refunded must instead be transferred to the Architect of the Capitol. The law directly affects those convicted or pardoned for involvement in the Capitol attack, blocking taxpayer-funded compensation for their actions.
HR 7685, the Healthy Hair Act, amends the Federal Food, Drug, and Cosmetic Act to classify hair straightening or smoothing products containing formaldehyde (or formaldehyde-releasing substances) as "adulterated" when sold across state lines after an 180-day grace period. It directly affects hair product manufacturers, salons, and workers who use or handle these products. The bill mandates a two-part study by the FDA and NIOSH on health impacts like cancer and respiratory issues for salon workers exposed to formaldehyde, requiring an initial report within one year and a final report within two years and two months. The study will inform future regulatory actions but does not ban formaldehyde products immediately.
